Results 171 to 180 of about 251,345 (303)

Targeted delivery of oral vaccine antigens to aminopeptidase N protects pigs against pathogenic E. coli challenge infection. [PDF]

Front Immunol, 2023
Van der Weken H, Jahantigh HR, Cox E, Devriendt B.   +3 more
europepmc   +1 more source

An Oral Vaccine Derived from Attenuated <i>Salmonella</i> Producing Murine Cytomegalovirus M24 Protein Induces Successful Antiviral Immune Responses in Mice. [PDF]

Vaccines (Basel)
Liu Y, Gong H, Zhu J, Liu F.
europepmc   +1 more source

Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control Mycoplasma hyopneumoniae in Swine Production. [PDF]

Int J Mol Sci, 2023
Storino GY, Petri FAM, Mechler-Dreibi ML, Aguiar GA, Toledo LT, Arruda LP, Malcher CS, Martins TS, Montassier HJ, Sant'Anna OA, Fantini MCA, de Oliveira LG.   +11 more
europepmc   +1 more source

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, EarlyView.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation. [PDF]

Mater Today Bio
Wang S, Jiang T, Jiang M, Miao YB.
europepmc   +1 more source

Aliphatic Poly(Carbonate)s with Acid Responsive Release Mechanisms for Micellar Anti‐Tumor Drug Delivery

Macromolecular Rapid Communications, EarlyView.
Micellar systems based on biodegradable aliphatic polycarbonates and acid‐responsive triggers enhance drug solubility, stability, and tumor‐selective release. This review covers micelles with acid‐cleavable drug linkages and those that disassemble via acid‐sensitive functionalities.
Adrian V. Hauck, Lutz Nuhn
wiley   +1 more source

Probiotic-based oral vaccine mucosal delivery system enabling genetically encoded dual-antigen arrays. [PDF]

Nat Commun
Yue Y, Xin Q, Zhu Y, Zhu D, Zhang B, Yan X, Jiang B.   +6 more
europepmc   +1 more source

Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome

Movement Disorders Clinical Practice, EarlyView.
Abstract Background There is widespread interest in complementary and integrative medicine (CIM) among people with Tourette's syndrome (TS). Objective To perform a systematic review of evidence on the use of CIM to reduce tics and improve tic‐related quality of life.
Tamara Pringsheim, Catherine Deans, Saar Anis, Poonam Bhatia, Kevin Black, Yildiz Degirmenci, Donald Gilbert, Andreas Hartmann, Mariam Hull, Irene Malaty, Davide Martino, Alex Medina Escobar, Pablo Mir, Christelle Nilles, Marianna Sarchioto, Jibrin Sammani Usman, Harini Sarva, Katarzyna Smilowksa, Natalia Szejko, Kinga Tomczak, Daniel van Wamelen, Yulia Worbe   +21 more
wiley   +1 more source

Development of a Mucosal Immune-Enhancing Oral Vaccine Candidate Against Porcine Epidemic Diarrhea Virus Using <i>Lactobacillus paracasei</i>. [PDF]

Animals (Basel)
Yang Y, Sui L, Zhao Y, Li J, Li F, Cui W, Jiang Y, Tang L, Zheng D, Wang X.   +9 more
europepmc   +1 more source

Yeasts in nanotechnology-enabled oral vaccine and gene delivery. [PDF]

Bioengineered, 2021
Ivanova E.
europepmc   +1 more source